Beijing Bohui Innovation Technology Co Ltd (300318) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.027x

Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.46 Million ≈ $-9.14 Million USD) by net assets (CN¥2.29 Billion ≈ $334.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300318 net asset quality index to measure how much of total assets are equity-financed.

Beijing Bohui Innovation Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 300318 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Beijing Bohui Innovation Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Bohui Innovation Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Exc Led Technology Co Ltd
SHE:300889
-0.024x
DXN HOLDINGS BHD.
KLSE:5318
0.066x
Unizyx Holding Corp
TW:3704
-0.042x
Foshan Nationstar Optoelectronics Co Ltd
SHE:002449
0.024x
SimilarWeb Ltd
NYSE:SMWB
0.012x
Newcapec Electronics Co Ltd
SHE:300248
0.022x
Shandong Lubei Chemical Co Ltd
SHG:600727
0.017x
Jinhe Biotechnology Co Ltd
SHE:002688
0.088x

Annual Cash Flow Conversion Efficiency for Beijing Bohui Innovation Technology Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Bohui Innovation Technology Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 300318 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.35 Billion
≈ $343.75 Million
CN¥-38.69 Million
≈ $-5.66 Million
-0.016x -128.13%
2023-12-31 CN¥2.34 Billion
≈ $342.50 Million
CN¥137.02 Million
≈ $20.05 Million
0.059x +234.10%
2022-12-31 CN¥2.32 Billion
≈ $340.06 Million
CN¥40.72 Million
≈ $5.96 Million
0.018x +1740.95%
2021-12-31 CN¥932.75 Million
≈ $136.49 Million
CN¥887.78K
≈ $129.91K
0.001x -98.41%
2020-12-31 CN¥1.44 Billion
≈ $210.56 Million
CN¥86.14 Million
≈ $12.60 Million
0.060x +274.83%
2019-12-31 CN¥1.05 Billion
≈ $153.96 Million
CN¥-36.03 Million
≈ $-5.27 Million
-0.034x +49.38%
2018-12-31 CN¥1.24 Billion
≈ $182.03 Million
CN¥-84.15 Million
≈ $-12.31 Million
-0.068x -14.67%
2017-12-31 CN¥1.61 Billion
≈ $236.13 Million
CN¥-95.19 Million
≈ $-13.93 Million
-0.059x -215.34%
2016-12-31 CN¥1.52 Billion
≈ $223.07 Million
CN¥77.97 Million
≈ $11.41 Million
0.051x -26.21%
2015-12-31 CN¥1.28 Billion
≈ $187.79 Million
CN¥88.95 Million
≈ $13.02 Million
0.069x +62.20%
2014-12-31 CN¥726.57 Million
≈ $106.32 Million
CN¥31.05 Million
≈ $4.54 Million
0.043x -45.49%
2013-12-31 CN¥702.55 Million
≈ $102.81 Million
CN¥55.08 Million
≈ $8.06 Million
0.078x -15.69%
2012-12-31 CN¥658.98 Million
≈ $96.43 Million
CN¥61.28 Million
≈ $8.97 Million
0.093x -50.52%
2011-12-31 CN¥249.52 Million
≈ $36.51 Million
CN¥46.89 Million
≈ $6.86 Million
0.188x +20.11%
2010-12-31 CN¥206.00 Million
≈ $30.14 Million
CN¥32.23 Million
≈ $4.72 Million
0.156x +16.48%
2009-12-31 CN¥169.62 Million
≈ $24.82 Million
CN¥22.79 Million
≈ $3.33 Million
0.134x +13.86%
2008-12-31 CN¥135.96 Million
≈ $19.89 Million
CN¥16.04 Million
≈ $2.35 Million
0.118x -49.74%
2007-12-31 CN¥99.25 Million
≈ $14.52 Million
CN¥23.30 Million
≈ $3.41 Million
0.235x +92.14%
2006-12-31 CN¥76.95 Million
≈ $11.26 Million
CN¥9.40 Million
≈ $1.38 Million
0.122x --

About Beijing Bohui Innovation Technology Co Ltd

SHE:300318 China Biotechnology
Market Cap
$577.37 Million
CN¥3.95 Billion CNY
Market Cap Rank
#11357 Global
#3146 in China
Share Price
CN¥4.83
Change (1 day)
+1.68%
52-Week Range
CN¥4.18 - CN¥8.17
All Time High
CN¥21.16
About

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more